Vai direttamente al contenuto

Otorinolaringoiatria: Chirurgia della Testa e del Collo

Rischi e incertezze delle emotrasfusioni

Anemia during sequential induction chemotherapy and chemoradiation for head and neck cancer: the impact of blood transfusion on treatment outcome. (apre una nuova finestra)

Bhide SA, Ahmed M, Rengarajan V, Powell C, Miah A, Newbold K, Nutting CM, Harrington KJ.

Fonte‎: Int J Radiat Oncol Biol Phys 2009;73(2):391-8.

Indicizzato‎: PubMed 18692326

DOI‎: 10.1016/j.ijrobp.2008.04.052

https://www.ncbi.nlm.nih.gov/pubmed/18692326 (apre una nuova finestra)

Does transfusion improve the outcome for HNSCC patients treated with radiotherapy?—results from the randomized DAHANCA 5 and 7 trials. (apre una nuova finestra)

Hoff CM, Lassen P, Eriksen JG, Hansen HS, Specht L, Overgaard M, Grau C, Johansen J, Bentzen J, Andersen L, Evensen JF, Overgaard J.

Fonte‎: Acta Oncol 2011;50(7):1006-14.

Indicizzato‎: PubMed 21790306

DOI‎: 10.3109/0284186X.2011.592650

https://www.ncbi.nlm.nih.gov/pubmed/21790306 (apre una nuova finestra)

Transfusion of allogenic leukocyte-depleted packed red blood cells is associated with postoperative morbidity in patients undergoing oral and oropharyngeal cancer surgery. (apre una nuova finestra)

Perisanidis C, Dettke M, Papadogeorgakis N, Schoppmann A, Mittlböck M, Kyzas PA, Ewers R, Seemann R.

Fonte‎: Oral Oncol 2012;48(4):372-8.

Indicizzato‎: PubMed 22182932

DOI‎: 10.1016/j.oraloncology.2011.11.020

https://www.ncbi.nlm.nih.gov/pubmed/22182932 (apre una nuova finestra)